Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR000043)
National Cancer Institute (P30CA008748, awarded to MSKCC)
Howard Hughes Medical Institute (NA)
IBM (NA, awarded to New York Genome Center)
Emerald Foundation (NA)
Text and Data Mining valid from 2019-04-25
Received: 11 September 2018
Accepted: 28 March 2019
First Online: 25 April 2019
Change Date: 2 August 2019
Change Type: Correction
Change Details: Following publication of the original article , it was reported that the given name of the fourteenth author was incorrectly published. The incorrect and the correct names are given below.
Ethics approval and consent to participate
: All participants provided written informed consent to participate. Protocols were approved by local or central Institutional Review Boards at: Rockefeller University, Biomedical Research Alliance of New York (on behalf of Northwell Health), Memorial Sloan Kettering Cancer Center, New York University School of Medicine, and Weill Cornell Medicine.
: Not applicable.
: MOF and RBD received consultant fees from New York Genome Center. TK, KH, and FU have patent applicatons related to Watson for Genomics, no. 14/745616. VV owns stock and options in 23andMe, Inc. MFLE received consultant fees from Rockefeller University. ABL in the past 12 months, received personal compensation (consulting fees/honoraria) from Northwest Biotherapeutics, AbbVie, Agios, Bioclinica, Sapience, WebMD, NCI; travel support from Karopharm, Northwest Biotherapeutics, Oncoceutis, Global Coalition for Adaptive Research, New York University, Agios, Abbvie, Celgene, Novocure, NRG Oncology Foundation, Tocagen, and Yale University; and research support (to the institution) from NCI, Oncoceutics, AbbVie, Karyopharm, Beigene, VBI Vaccines, Kadmon, Pfizer, RTOG-Foundation, Aeterna Zentaris, Northwestern University, Novartis, Pfizer, Celldex, Millenium, UCLA, and Amgen. NR, AKE, BJC, KA, MS, HG, VF, ED, SR, AF, EAB, JLMV, CR, DKhaira, AC, DKim, CE, PA, CS, JB, AD, DGP, JGG, CB, JF, PC, CG, MD, ED, AO, EP, DEO, SJH, JBP, VVM, VJ, MCZ, JK, LP, KOW and AKR declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.